Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2047-01
Published April 1, 2020 · Recall initiated: March 23, 2020
Summary
FDA records drug Class III recall D-1057-2020, published April 1, 2020 and initiated March 23, 2020. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 3,816 botlles; Lot: Lot # 3105410, 3106268, Exp 9/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.
What to do
Voluntary: Firm initiated · Letter
Get an email if TACROLIMUS has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TACROLIMUS
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- U.S.A. Nationwide
- UPC
- 0303782046014
- Lot
- Lot # 3105410, 3106268, Exp 9/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited,January 17, 2024
- FDATacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited,March 1, 2023
- FDATacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDCAugust 10, 2022
- FDABuprenorphine Black Cherry 2 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, ThriveApril 1, 2020
- FDATheophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: NostrumApril 1, 2020
- FDATacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd.January 1, 2014
Questions about this recall
Was Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2047-01 recalled?
Yes. FDA published recall D-1057-2020 on April 1, 2020. Reported hazard: Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TACROLIMUS. UPC: 0303782046014.